Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening
Oral cancer is one of the most common cancers globally. Survival rates for patients are directly correlated with stage of diagnosis; despite this knowledge, 60% of individuals are presenting with late-stage disease. Currently, the initial evaluation of a questionable lesion is performed by a convent...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-11-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.1177/1536012118808644 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832544624681418752 |
|---|---|
| author | Arianna Strome BS Susanne Kossatz PhD Daniella Karassawa Zanoni MD Milind Rajadhyaksha PhD Snehal Patel MD Thomas Reiner PhD |
| author_facet | Arianna Strome BS Susanne Kossatz PhD Daniella Karassawa Zanoni MD Milind Rajadhyaksha PhD Snehal Patel MD Thomas Reiner PhD |
| author_sort | Arianna Strome BS |
| collection | DOAJ |
| description | Oral cancer is one of the most common cancers globally. Survival rates for patients are directly correlated with stage of diagnosis; despite this knowledge, 60% of individuals are presenting with late-stage disease. Currently, the initial evaluation of a questionable lesion is performed by a conventional visual examination with white light. If a lesion is deemed suspicious, a biopsy is taken for diagnosis. However, not all lesions present suspicious under visual white light examination, and there is limited specificity in differentiating between benign and malignant transformations. Several vital dyes, light-based detection systems, and cytology evaluation methods have been formulated to aid in the visualization process, but their lack of specific biomarkers resulted in high false-positive rates and thus limits their reliability as screening and guidance tools. In this review, we will analyze the current methodologies and demonstrate the need for specific intraoral imaging agents to aid in screening and diagnosis to identify patients earlier. Several novel molecular imaging agents will be presented as, by result of their molecular targeting, they aim to have high specificity for tumor pathways and can support in identifying dysplastic/cancerous lesions and guiding visualization of biopsy sites. Imaging agents that are easy to use, inexpensive, noninvasive, and specific can be utilized to increase the number of patients who are screened and monitored in a variety of different environments, with the ultimate goal of increasing early detection. |
| format | Article |
| id | doaj-art-814780a663a44efba0b6bcfa493a39df |
| institution | Kabale University |
| issn | 1536-0121 |
| language | English |
| publishDate | 2018-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Molecular Imaging |
| spelling | doaj-art-814780a663a44efba0b6bcfa493a39df2025-02-03T10:08:01ZengSAGE PublishingMolecular Imaging1536-01212018-11-011710.1177/1536012118808644Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer ScreeningArianna Strome BS0Susanne Kossatz PhD1Daniella Karassawa Zanoni MD2Milind Rajadhyaksha PhD3Snehal Patel MD4Thomas Reiner PhD5 Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Radiology, Weill-Cornell Medical College, New York, NY, USAOral cancer is one of the most common cancers globally. Survival rates for patients are directly correlated with stage of diagnosis; despite this knowledge, 60% of individuals are presenting with late-stage disease. Currently, the initial evaluation of a questionable lesion is performed by a conventional visual examination with white light. If a lesion is deemed suspicious, a biopsy is taken for diagnosis. However, not all lesions present suspicious under visual white light examination, and there is limited specificity in differentiating between benign and malignant transformations. Several vital dyes, light-based detection systems, and cytology evaluation methods have been formulated to aid in the visualization process, but their lack of specific biomarkers resulted in high false-positive rates and thus limits their reliability as screening and guidance tools. In this review, we will analyze the current methodologies and demonstrate the need for specific intraoral imaging agents to aid in screening and diagnosis to identify patients earlier. Several novel molecular imaging agents will be presented as, by result of their molecular targeting, they aim to have high specificity for tumor pathways and can support in identifying dysplastic/cancerous lesions and guiding visualization of biopsy sites. Imaging agents that are easy to use, inexpensive, noninvasive, and specific can be utilized to increase the number of patients who are screened and monitored in a variety of different environments, with the ultimate goal of increasing early detection.https://doi.org/10.1177/1536012118808644 |
| spellingShingle | Arianna Strome BS Susanne Kossatz PhD Daniella Karassawa Zanoni MD Milind Rajadhyaksha PhD Snehal Patel MD Thomas Reiner PhD Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening Molecular Imaging |
| title | Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening |
| title_full | Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening |
| title_fullStr | Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening |
| title_full_unstemmed | Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening |
| title_short | Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening |
| title_sort | current practice and emerging molecular imaging technologies in oral cancer screening |
| url | https://doi.org/10.1177/1536012118808644 |
| work_keys_str_mv | AT ariannastromebs currentpracticeandemergingmolecularimagingtechnologiesinoralcancerscreening AT susannekossatzphd currentpracticeandemergingmolecularimagingtechnologiesinoralcancerscreening AT daniellakarassawazanonimd currentpracticeandemergingmolecularimagingtechnologiesinoralcancerscreening AT milindrajadhyakshaphd currentpracticeandemergingmolecularimagingtechnologiesinoralcancerscreening AT snehalpatelmd currentpracticeandemergingmolecularimagingtechnologiesinoralcancerscreening AT thomasreinerphd currentpracticeandemergingmolecularimagingtechnologiesinoralcancerscreening |